2-(1,1'-BIPHENYL)-4-YL-5-(2-NAPHTHYL)-1,3,4-OXADIAZOLE
UNII 4JR8X5MY5D

Substance Identification & Data

This profile provides standardized clinical and technical data for 2-(1,1'-biphenyl)-4-yl-5-(2-naphthyl)-1,3,4-oxadiazole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4JR8X5MY5D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1103-59-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4JR8X5MY5D

CAS Registry Number

1103-59-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

2-(1,1'-BIPHENYL)-4-YL-5-(2-NAPHTHYL)-1,3,4-OXADIAZOLE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C24H16N2O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

AASNQZPKNMLTHY-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

70674

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

o1c(nnc1-c2ccc(cc2)-c3ccccc3)-c4cc5ccccc5cc4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 2-(1,1'-biphenyl)-4-yl-5-(2-naphthyl)-1,3,4-oxadiazole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.